Buscar
Mostrando ítems 1-5 de 5
Circulating Sclerostin in Disorders of Parathyroid Gland Function
(Endocrine Soc, 2011-12-01)
Context: Sclerostin, a protein encoded by the SOST gene in osteocytes and an antagonist of the Wnt signaling pathway, is down-regulated by PTH administration. Disorders of parathyroid function are useful clinical settings ...
Expression of Fibroblast Growth Factor 23, Vitamin D Receptor, and Sclerostin in Bone Tissue from Hypercalciuric Stone Formers
(Amer Soc Nephrology, 2014-07-07)
Background and objectives Increased bone resorption, low bone formation, and abnormal mineralization have been described in stone formers with idiopathic hypercalciuria. It has been previously shown that the receptor ...
Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease
(Nature Publishing Group, 2015-05-01)
Chronic kidney disease-mineral bone disorder (CKD-MBD) is a complex syndrome influenced by various factors, such as age, CKD etiology, uremic toxins, and dialysis modality. Although extensively studied in hemodialysis (HD) ...
Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease
(Nature Publishing Group, 2015)
Effect of Aerobic Exercise on Markers of Bone Metabolism of Overweight and Obese Patients With Chronic Kidney Disease
(W B Saunders Co-Elsevier Inc, 2017)
Objective: The aim of the study was to investigate the effect of aerobic exercise on markers of bone metabolism in overweight and obese nondialysis-dependent patients with chronic kidney disease. Methods: This is a post-hoc ...